Cita APA (7a ed.)

MA, V. (2010). Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. Dove Medical Press.

Cita Chicago Style (17a ed.)

MA, Via. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.

Cita MLA (8a ed.)

MA, Via. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.